NCT01435915View on ClinicalTrials.gov

Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 28, 2010

Primary Completion Date

August 5, 2010

Study Completion Date

August 5, 2010

Conditions
Parkinson Disease
Interventions
DRUG

Ropinirole

"Ropinirole 2 milligrams once daily prolonged release tablet will be given at 24-hour intervals in the morning.~Single and repeat dose treatment periods will be separated by 7 days of washout period."

Trial Locations (1)

100032

GSK Investigational Site, Beijing

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY